TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN

AC T08464 XX ID T08464 XX DT 23.01.2006 (created); jag. DT 15.04.2016 (updated); hna. CO Copyright (C), QIAGEN. XX FA C/EBPalpha XX SY BPc; C/EBP; C/EBP alpha; C/EBPalpha; C/EBPalpha(p42); CBP; CCAAT Enhancer Binding Protein alpha; CCAAT/enhancer binding protein alpha; CEBPA; EBP20; p42(C/EBPalpha); p42C/EBPalpha. XX OS mouse, Mus musculus OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; rodentia; myomorpha; muridae; murinae XX GE G000490 Cebpa. XX CL C0008; bZIP; XX FF The affinity of C/EBPalpha binding to Nupr1 G042247 promoter is higher than C/EBPbeta [5]; XX IN T08464 C/EBPalpha; mouse, Mus musculus. IN T04203 FOXO1A; mouse, Mus musculus. IN T01302 GATA-2; mouse, Mus musculus. IN T16993 MIBP1; mouse, Mus musculus. IN T08563 NF-YA; Mammalia. IN T22189 RECC1; mouse, Mus musculus. IN T10505 TTF-1; Mammalia. XX MX M00116 V$CEBPA_01. MX M07412 V$CEBPA_04. MX M07037 V$CEBPA_Q4. MX M01866 V$CEBPA_Q6. MX M00159 V$CEBP_01. MX M00201 V$CEBP_C. MX M00190 V$CEBP_Q2. MX M00912 V$CEBP_Q2_01. MX M00770 V$CEBP_Q3. MX M00249 V$CHOP_01. XX BS R39946. BS R57365. BS R57366. BS R32278. BS R36013. BS R38277. BS R20520. BS R29866. BS R29867. BS R29868. BS R23180. BS R37773. BS R20524. BS R31971. BS R39907. BS R39908. BS R42260. BS R42264. BS R32324. BS R60521. BS R20625. BS R41835. BS R03135. BS R28460. BS R28369. BS R28370. BS R61577. BS R37804. BS R37806. BS R62515. BS R73123. BS R64373. BS R33469. BS R62523. BS R62525. BS R37049. BS R67676. BS R67677. BS R23524. BS R36284. BS R26887. BS R20515. BS R26872. BS R21754. BS R66204. BS R29474. BS R62741. BS R62742. BS R67929. BS R67930. BS R33702. BS R33703. BS R33709. BS R33705. BS R23087. BS R64700. BS R63925. BS R66205. BS R66209. BS R39451. BS R64245. BS R72787. BS R72788. BS R67816. BS R60860. BS R21609. BS R00097. BS R34581. XX DR TRANSPATH: MO000058349. DR TRANSCOMPEL: C00456. DR TRANSCOMPEL: C00585. DR UniProtKB: P53566; XX RN [1]; RE0025710. RX PUBMED: 11867521. RA Wang H., Goode T., Iakova P., Albrecht J. H., Timchenko N. A. RT C/EBPalpha triggers proteasome-dependent degradation of cdk4 during growth arrest. RL EMBO J. 21:930-41 (2002). RN [2]; RE0032033. RX PUBMED: 12757710. RA Iakova P., Awad S. S., Timchenko N. A. RT Aging reduces proliferative capacities of liver by switching pathways of C/EBPalpha growth arrest. RL Cell 113:495-506 (2003). RN [3]; RE0035887. RX PUBMED: 14701740. RA Ross S. E., Radomska H. S., Wu B., Zhang P., Winnay J. N., Bajnok L., Wright W. S., Schaufele F., Tenen D. G., MacDougald O. A. RT Phosphorylation of C/EBPalpha inhibits granulopoiesis. RL Mol. Cell. Biol. 24:675-686 (2004). RN [4]; RE0036169. RX PUBMED: 15632071. RA Tong Q., Tsai J., Tan G., Dalgin G., Hotamisligil G. S. RT Interaction between GATA and the C/EBP family of transcription factors is critical in GATA-mediated suppression of adipocyte differentiation. RL Mol. Cell. Biol. 25:706-715 (2005). RN [5]; RE0041442. RX PUBMED: 10510303. RA Vasseur S., Mallo G. V., Garcia-Montero A., Ortiz E. M., Fiedler F., Canepa E., Moreno S., Iovanna J. L. RT Structural and functional characterization of the mouse p8 gene: promotion of transcription by the CAAT-enhancer binding protein alpha (C/EBPalpha) and C/EBPbeta trans-acting factors involves a C/EBP cis-acting element and other regions of the promoter RL Biochem. J. 343:377-83 (1999). RN [6]; RE0042688. RX PUBMED: 11684017. RA Wang H., Iakova P., Wilde M., Welm A., Goode T., Roesler W. J., Timchenko N. A. RT C/EBPalpha arrests cell proliferation through direct inhibition of Cdk2 and Cdk4 RL Mol. Cell 8:817-28 (2001). RN [7]; RE0047660. RX PUBMED: 12727880. RA Wiper-Bergeron N., Wu D., Pope L., Schild-Poulter C., Hache R. J. RT Stimulation of preadipocyte differentiation by steroid through targeting of an HDAC1 complex. RL EMBO J. 22:2135-2145 (2003). RN [8]; RE0048262. RX PUBMED: 16210377. RA Singh R., Artaza J. N., Taylor W. E., Braga M., Yuan X., Gonzalez-Cadavid N. F., Bhasin S. RT Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. RL Endocrinology 147:141-154 (2006). RN [9]; RE0048349. RX PUBMED: 11356826. RA Hong S., Park S. J., Kong H. J., Shuman J. D., Cheong J. RT Functional interaction of bZIP proteins and the large subunit of replication factor C in liver and adipose cells. RL J. Biol. Chem. 276:28098-28105 (2001). RN [10]; RE0048488. RX PUBMED: 15691842. RA Yu C., Markan K., Temple K. A., Deplewski D., Brady M. J., Cohen R. N. RT The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor gamma transcriptional activity and repress 3T3-L1 adipogenesis. RL J. Biol. Chem. 280:13600-13605 (2005). RN [11]; RE0048515. RX PUBMED: 16644732. RA McFie P. J., Wang G. L., Timchenko N. A., Wilson H. L., Hu X., Roesler W. J. RT Identification of a co-repressor that inhibits the transcriptional and growth-arrest activities of CCAAT/enhancer-binding protein alpha. RL J. Biol. Chem. 281:18069-18080 (2006). RN [12]; RE0048532. RX PUBMED: 16595692. RA Xu Y., Zhou Y. L., Luo W., Zhu Q. S., Levy D., MacDougald O. A., Snead M. l. RT NF-Y and CCAAT/enhancer-binding protein alpha synergistically activate the mouse amelogenin gene. RL J. Biol. Chem. 281:16090-16098 (2006). RN [13]; RE0050196. RX PUBMED: 15987634. RA Bouaboula M., Hilairet S., Marchand J., Fajas L., Le Fur G., Casellas P. RT Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation. RL Eur. J. Pharmacol. 517:174-181 (2005). RN [14]; RE0053554. RX PUBMED: 16807249. RA Qiao L., MacDougald O. A., Shao J. RT CCAAT/enhancer-binding protein alpha mediates induction of hepatic phosphoenolpyruvate carboxykinase by p38 mitogen-activated protein kinase. RL J. Biol. Chem. 281:24390-24397 (2006). RN [15]; RE0065384. RX PUBMED: 15930175. RA Hogan J. C., Stephens J. M. RT Effects of leukemia inhibitory factor on 3T3-L1 adipocytes. RL J. Endocrinol. 185:485-496 (2005). XX //